サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413944

アデノシン三リン酸（ATP）アッセイの世界市場レポート 2024年

Adenosine Triphosphate (ATP) Assays Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アデノシン三リン酸（ATP）アッセイの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

アデノシン三リン酸（ATP）アッセイの市場規模は近年急速に拡大しています。2023年の17億7,000万米ドルから2024年には19億7,000万米ドルへと、CAGR11.2％で拡大します。この期間に見られた拡大は、生物医学研究の進展、創薬研究開発の進歩、臨床診断における採用の増加、環境モニタリングの需要の高まり、細胞ベースアッセイの重視の高まりによるものです。

アデノシン三リン酸（ATP）アッセイの市場規模は今後数年で急成長が見込まれます。2028年にはCAGR11.2％で30億1,000万米ドルに成長します。予測期間の拡大は、バイオ医薬品産業の持続的成長、個別化医療アプローチの導入拡大、飲食品の安全性確保への注目の高まり、アッセイプラットフォームの技術革新、工業プロセスへの応用の増加などに起因すると考えられます。主な予測動向としては、ATP検出技術の進歩、ハイスループット・スクリーニングの需要拡大、臨床診断への統合、飲食品安全性試験の重視、スポーツやパフォーマンス・モニタリングへの応用拡大などが挙げられます。

がん、慢性疾患、感染症の発生が予想されることから、アデノシン三リン酸（ATP）アッセイ市場の今後の拡大が見込まれます。調節不能な細胞増殖を特徴とするがん、長期持続性の慢性疾患、病原微生物による感染症は、総体的にATPアッセイの需要に寄与しています。これらのアッセイは、細胞生存能の評価、微生物汚染の検出、治療効果のモニタリング、代謝およびミトコンドリア機能不全の評価など、重要な診断ツールとしての役割を果たしています。一例として、2022年10月に世界保健機関（WHO）が発表したデータによると、2021年には約1,060万人が結核に罹患し、HIV陽性者18万7,000人を含む160万人が死亡したと記録されています。さらに、国際糖尿病連合は2021年に、約5億3,700万人の成人が糖尿病を患っていると報告し、その数は2045年までに7億8,300万人にまで拡大すると予測しました。このように、がん、慢性疾患、感染症の有病率の増加は、アデノシン三リン酸（ATP）アッセイ市場の原動力となっています。

個別化治療アプローチに対する需要の高まりが、アデノシン三リン酸（ATP）アッセイ市場の拡大を後押しすると期待されています。個別化治療とは、病気の予防、発見、治療を効果的に行うために、個人に固有の遺伝子やタンパク質の構成に関する知識を活用することです。感染症管理においては、特定の病原体に対する抗菌剤の有効性を評価し、個別化された治療戦略の選択を支援するATPアッセイが重要な役割を果たしています。例えば、米国食品医薬品局（FDA）は2022年に12の個別化医薬品を承認しており、これは個別化医療連合（Personalized Medicine Coalition）の報告によると、新たに承認された全治療用分子実体の約34％を占める。このような個別化医療に対する需要の急増は、アデノシン三リン酸（ATP）アッセイ市場の成長を促進する上で極めて重要な役割を担っていることを裏付けています。

2023年のアデノシン三リン酸（ATP）アッセイ市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域と予想されています。アデノシン三リン酸（ATP）アッセイ市場レポート対象地域：アジア太平洋、西欧、東欧、北米、南米、中東・アフリカ

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のアデノシン三リン酸（ATP）アッセイ市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のアデノシン三リン酸（ATP）アッセイの市場規模実績と成長、2018年～2023年
  • 世界のアデノシン三リン酸（ATP）アッセイ市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のアデノシン三リン酸（ATP）アッセイ市場、タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 発光ATP（アデノシン三リン酸）アッセイ
  • 酵素的 ATP（アデノシン三リン酸）アッセイ
  • 生物発光共鳴エネルギー移動（BRET）ATP（アデノシン三リン酸）アッセイ
  • 細胞ベースのATP（アデノシン三リン酸）アッセイ
  • その他のタイプ
  • 世界のアデノシン三リン酸（ATP）アッセイ市場、成分別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 消耗品と付属品
  • 機器
  • 世界のアデノシン三リン酸（ATP）アッセイ市場、用途別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 創薬・開発
  • 臨床診断
  • 環境試験
  • 食品の安全性と品質検査
  • その他の用途
  • 世界のアデノシン三リン酸（ATP）アッセイ市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023年～2028年、2033年
  • 製薬会社・バイオテクノロジー会社
  • 飲食業界
  • 病院と診断研究所
  • 学術研究機関

第7章 地域および国の分析

  • 世界のアデノシン三リン酸（ATP）アッセイ市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界のアデノシン三リン酸（ATP）アッセイ市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • アデノシン三リン酸（ATP）アッセイ市場の競合情勢
  • アデノシン三リン酸（ATP）アッセイ市場の企業プロファイル
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • PerkinElmer Inc.
    • Lonza Group
    • Promega Corporation

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11454

“Adenosine Triphosphate (ATP) Assays Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adenosine triphosphate (apt) assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adenosine triphosphate (apt) assays? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The adenosine triphosphate (apt) assays market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays; Enzymatic ATP (Adenosine Triphosphate) Assays; Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays; Cell-Based ATP (Adenosine Triphosphate) Assays; Other Types
  • 2) By Component: Consumables And Accessories; Instruments
  • 3) By Application: Drug Discovery And Development; Clinical Diagnostics; Environmental Testing; Food Safety And Quality Testing; Other Applications
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Food and Beverage Industry; Hospitals And Diagnostics Laboratories; Academic And Research Institutions
  • Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Lonza Group; Promega Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

ATP assays, or adenosine triphosphate assays, serve as analytical procedures to determine ATP concentrations in biological materials. ATP, an energy-carrying molecule present in cells of all living organisms, extracts chemical energy from the breakdown of food molecules and utilizes it to power various cellular functions. This assay plays a crucial role in monitoring cellular energy state and function, serving as a vital tool in research, diagnostics, and drug discovery.

The primary types of ATP assays include luminometric ATP assays, enzymatic ATP assays, bioluminescence resonance energy transfer (BRET) ATP assays, cell-based ATP assays, among others. Luminometric ATP assays, specifically, leverage bioluminescence principles to measure ATP levels in samples. They are widely used in research, drug discovery, and biomedical applications for assessing cellular energy status, measuring enzymatic activity, evaluating cell viability, and screening ATP-modulating compounds. These assays consist of essential components such as consumables, accessories, and instruments utilized across diverse fields including drug discovery and development, clinical diagnostics, environmental testing, and food safety and quality assessment. Their applications extend to various end-users such as pharmaceutical and biotechnology companies, the food and beverage industry, hospitals, diagnostics laboratories, as well as academic and research institutions.

The adenosine triphosphate (ATP) assays market research report is one of a series of new reports from The Business Research Company that provides adenosine triphosphate (ATP) assays market statistics, including adenosine triphosphate (ATP) assays industry global market size, regional shares, competitors with an adenosine triphosphate (ATP) assays market share, detailed adenosine triphosphate (ATP) assays market segments, market trends and opportunities, and any further data you may need to thrive in the adenosine triphosphate (ATP) assays industry. This adenosine triphosphate (ATP) assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adenosine triphosphate (atp) assays market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The expansion observed in the historical period can be credited to progress in biomedical research, advancements in drug discovery and development, heightened adoption in clinical diagnostics, growing demands for environmental monitoring, and an increased emphasis on cell-based assays.

The adenosine triphosphate (atp) assays market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated expansion in the forecast period can be attributed to the sustained growth of the biopharmaceutical industry, the widening implementation of personalized medicine approaches, heightened focus on ensuring food and beverage safety, technological innovations in assay platforms, and the increasing application in industrial processes. Major forecasted trends encompass advancements in ATP detection technologies, a growing demand for high-throughput screening, integration into clinical diagnostics, an emphasis on food and beverage safety testing, and expanded application in sports and performance monitoring.

The anticipated rise in the occurrence of cancer, chronic ailments, and infectious diseases is poised to drive the expansion of the adenosine triphosphate (ATP) assay market in the future. Cancer, characterized by unregulated cell growth, chronic conditions with prolonged persistence, and infectious diseases caused by pathogenic microorganisms, collectively contribute to the demand for ATP assays. These assays serve as crucial diagnostic tools, assessing cellular viability, detecting microbial contamination, monitoring treatment effectiveness, and evaluating metabolic and mitochondrial dysfunction. As an example, data from the World Health Organization in October 2022 indicated that approximately 10.6 million individuals were affected by tuberculosis (TB) in 2021, with 1.6 million fatalities recorded, including 187,000 HIV-positive individuals. Additionally, the International Diabetes Federation reported in 2021 that around 537 million adults were living with diabetes, a number projected to escalate to 783 million by 2045. Thus, the increasing prevalence of cancer, chronic ailments, and infectious diseases acts as a driving force behind the adenosine triphosphate (ATP) assay market.

The growing demand for personalized treatment approaches is expected to fuel the expansion of the adenosine triphosphate (ATP) assays market. Personalized treatments involve utilizing knowledge about an individual's unique genetic or protein makeup to prevent, detect, or treat diseases effectively. In the context of infectious disease management, ATP assays play a crucial role by assessing the efficacy of antimicrobial agents against specific pathogens, aiding in the selection of personalized treatment strategies. For instance, the US Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition. This surge in demand for personalized medicine underscores its pivotal role in driving the growth of the adenosine triphosphate (ATP) assays market.

The evolution of novel assays stands out as a prominent trend gaining momentum within the adenosine triphosphate (ATP) assay market. Key companies operating in this domain are introducing groundbreaking products, such as the SensiLux kit by BC Aplicaciones, a biotechnology firm based in Spain. The SensiLux kit is a unique testing solution designed for detecting microbial ATP in samples, utilizing bioluminescence for detection following sample pre-incubation. Its applications extend to areas such as food safety and contamination testing. Additionally, this offering includes ATP kits featuring advanced multi-injector automatic luminometers, proprietary control software, and future-oriented robot-based sample automation, providing customers with tailored solutions. BC Aplicaciones' programming and computer systems department have developed unique software to manage robot and luminometer operations.

Major players in the ATP assay market are directing their focus towards innovative solutions such as the AccuPoint Advanced Next Generation (NG) to bolster their market presence. This comprehensive sanitation monitoring system is engineered to validate and confirm the efficacy of sanitation programs by identifying organic residues lingering on surfaces and in liquids post-cleaning. For instance, in May 2021, Neogen Corporation, a US-based food safety entity, introduced the AccuPoint Advanced NG system, comprising a handheld instrument, innovative samplers, and data manager software. This system functions by measuring adenosine triphosphate (ATP), rendering the invisible visible and furnishing a reliable, consistent, and documented dataset on sanitation effectiveness. Offering automated data reporting, trend tracking, and audit functionalities, the AccuPoint Advanced NG system is designed to enhance sanitation testing across diverse sectors such as food safety, healthcare, and environmental monitoring.

In October 2021, Abcam plc, a UK-based biotechnology enterprise, completed the acquisition of BioVision Inc for $340 million. This strategic acquisition aimed to augment Abcam's capabilities, expanding its cellular assay portfolio in critical domains such as oncology, immuno-oncology, neuroscience, and epigenetics. The acquisition of BioVision, a US-based manufacturer specializing in ATP assays and test kits, empowered Abcam to gain a competitive edge and scale up its operations significantly within the market.

Major companies operating in the adenosine triphosphate (atp) assays market report are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, 3M Co., Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adenosine triphosphate (atp) assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adenosine triphosphate (ATP) assays market consists of revenues earned by entities by providing testing services related to colorimetric and fluorescent assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The adenosine triphosphate (ATP) assays market also includes sales of luminometer, and chemiluminescent which are used in adenosine triphosphate (ATP) assay services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Adenosine Triphosphate (ATP) Assays Market Characteristics

3. Adenosine Triphosphate (ATP) Assays Market Trends And Strategies

4. Adenosine Triphosphate (ATP) Assays Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Adenosine Triphosphate (ATP) Assays Market Size and Growth

  • 5.1. Global Adenosine Triphosphate (ATP) Assays Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Adenosine Triphosphate (ATP) Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Adenosine Triphosphate (ATP) Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Adenosine Triphosphate (ATP) Assays Market Segmentation

  • 6.1. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Luminometric ATP (Adenosine Triphosphate) Assays
  • Enzymatic ATP (Adenosine Triphosphate) Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays
  • Cell-Based ATP (Adenosine Triphosphate) Assays
  • Other Types
  • 6.2. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables And Accessories
  • Instruments
  • 6.3. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery And Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety And Quality Testing
  • Other Applications
  • 6.4. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Food and Beverage Industry
  • Hospitals And Diagnostics Laboratories
  • Academic And Research Institutions

7. Adenosine Triphosphate (ATP) Assays Market Regional And Country Analysis

  • 7.1. Global Adenosine Triphosphate (ATP) Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Adenosine Triphosphate (ATP) Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market

  • 8.1. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Adenosine Triphosphate (ATP) Assays Market

  • 9.1. China Adenosine Triphosphate (ATP) Assays Market Overview
  • 9.2. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Adenosine Triphosphate (ATP) Assays Market

  • 10.1. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Adenosine Triphosphate (ATP) Assays Market

  • 11.1. Japan Adenosine Triphosphate (ATP) Assays Market Overview
  • 11.2. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Adenosine Triphosphate (ATP) Assays Market

  • 12.1. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Adenosine Triphosphate (ATP) Assays Market

  • 13.1. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Adenosine Triphosphate (ATP) Assays Market

  • 14.1. South Korea Adenosine Triphosphate (ATP) Assays Market Overview
  • 14.2. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Adenosine Triphosphate (ATP) Assays Market

  • 15.1. Western Europe Adenosine Triphosphate (ATP) Assays Market Overview
  • 15.2. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Adenosine Triphosphate (ATP) Assays Market

  • 16.1. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Adenosine Triphosphate (ATP) Assays Market

  • 17.1. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Adenosine Triphosphate (ATP) Assays Market

  • 18.1. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Adenosine Triphosphate (ATP) Assays Market

  • 19.1. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Adenosine Triphosphate (ATP) Assays Market

  • 20.1. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Adenosine Triphosphate (ATP) Assays Market

  • 21.1. Eastern Europe Adenosine Triphosphate (ATP) Assays Market Overview
  • 21.2. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Adenosine Triphosphate (ATP) Assays Market

  • 22.1. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Adenosine Triphosphate (ATP) Assays Market

  • 23.1. North America Adenosine Triphosphate (ATP) Assays Market Overview
  • 23.2. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Adenosine Triphosphate (ATP) Assays Market

  • 24.1. USA Adenosine Triphosphate (ATP) Assays Market Overview
  • 24.2. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Adenosine Triphosphate (ATP) Assays Market

  • 25.1. Canada Adenosine Triphosphate (ATP) Assays Market Overview
  • 25.2. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Adenosine Triphosphate (ATP) Assays Market

  • 26.1. South America Adenosine Triphosphate (ATP) Assays Market Overview
  • 26.2. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Adenosine Triphosphate (ATP) Assays Market

  • 27.1. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Adenosine Triphosphate (ATP) Assays Market

  • 28.1. Middle East Adenosine Triphosphate (ATP) Assays Market Overview
  • 28.2. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Adenosine Triphosphate (ATP) Assays Market

  • 29.1. Africa Adenosine Triphosphate (ATP) Assays Market Overview
  • 29.2. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape And Company Profiles

  • 30.1. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape
  • 30.2. Adenosine Triphosphate (ATP) Assays Market Company Profiles
    • 30.2.1. Merck KGaA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. PerkinElmer Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lonza Group
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Promega Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking

32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Adenosine Triphosphate (ATP) Assays Market

34. Adenosine Triphosphate (ATP) Assays Market Future Outlook and Potential Analysis

  • 34.1 Adenosine Triphosphate (ATP) Assays Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Adenosine Triphosphate (ATP) Assays Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Adenosine Triphosphate (ATP) Assays Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer